In the present study, KCNMB2 expression level was markedly reduced in CS exposure-induced COPD rat models and COPD smoker patients and may be attributed in promoting pulmonary vasoconstriction and arterial remodeling. The gene discussed is KCNMB2; the disease is chronic obstructive pulmonary disease.